Skip to main content
UCB's Global Corporate Website
instagram
facebook
twitter
youtube
linkedin
rss
Listen
6 Mar 2014
Transparency notification of Vanguard Health Care Fund
Read More
27 Feb 2014
UCB Convertible Bond and update on share capital, securities carrying voting rights and voting rights
Read More
26 Feb 2014
Growth of core medicines in 2013 creates a strong foundation at start of new era
Read More
20 Feb 2014
UCB announces CEO succession plan in anticipation of next wave of product launches
Read More
30 Jan 2014
UCB and Biogen Idec Enter Agreement To Commercialize Multiple Sclerosis and Hemophilia Therapies in Asia
Read More
21 Jan 2014
Notice of Early Redemption of EUR 500,000,000 4.50 per cent. Convertible Bonds due 2015
Read More
16 Jan 2014
UCB SA/NV Convertible Bond Early Redemption Option
Read More
15 Jan 2014
Update of transparency notification
Read More
13 Jan 2014
Transparency notification of The Capital Group Companies Inc.
Read More
13 Jan 2014
Acquisition of own shares
Read More
Pagination
First page
Previous page
‹ Previous
…
Page
48
Page
49
Page
50
Page
51
Current page
52
Page
53
Page
54
Page
55
Page
56
…
Next page
Next ›
Last page
Subscribe to
Choose a Country
Global Site – English
Australia – English
België – Engels
Belgique – Anglais
Brasil – Português
България – Български
Canada – English
Canada – Français
中国 – 中文
Česká Republika – Angličtina
Danmark – Engelsk
Deutschland – Deutsch
France – Français
España – Español
Ελλάδα – Ελληνικά
India – English
Ireland – English
Italia – Inglese
日本 – 日本語
한국 – 한국어
Luxembourg – Anglais
Luxemburg – Engels
Magyarország – Angol
México & Latinoamérica – Español
Nederland – Engels
New Zealand – English
Norge – Engelsk
Österreich – Deutsch
Polska – Polski
Portugal – español y portugués
România – Engleză
Россия – Русский
Slovensko – Anglický
Suomi – Englanti
Sverige – Engelska
Schweiz – Deutsch
Türkiye – Türkçe
Україна – Англійська
United Kingdom – English
U.S.A. – English
×
instagram
facebook
twitter
youtube
linkedin
rss